Status:
COMPLETED
Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
Study A6631027 will evaluate the safety, tolerability and pharmacokinetics of PH-797804 when administered to healthy Japanese subjects once a day (QD) for 10 days.
Eligibility Criteria
Inclusion
- Healthy Volunteers
- Japanese
Exclusion
- Subjects with clinically significant skin lesions
- Subjects with known tuberculosis infection
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01217918
Start Date
October 1 2010
End Date
February 1 2011
Last Update
February 15 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Culver City, California, United States, 90232
2
Pfizer Investigational Site
Glendale, California, United States, 91206